130 related articles for article (PubMed ID: 25234444)
21. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
22. Myofibroblast presence in apparently normal mucosa adjacent to oral squamous cell carcinoma associated with chronic tobacco/areca nut use: evidence for field cancerization.
Angadi PV; Patil PV; Kale AD; Hallikerimath S; Babji D
Acta Odontol Scand; 2014 Oct; 72(7):502-8. PubMed ID: 24359586
[TBL] [Abstract][Full Text] [Related]
23. [Ki-67 and claudin-1 expression in hyperplasia, oral squamous inthraepithelial neoplasia and oral squamous cell carcinoma].
Ivina AA; Babichenko II; Rabinovich OF; Togonidze AA
Stomatologiia (Mosk); 2014; 93(1):31-3. PubMed ID: 24576965
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 beta in oral submucous fibrosis, verrucous hyperplasia and squamous cell carcinoma tissues.
Tsai CC; Chen CC; Lin CC; Chen CH; Lin TS; Shieh TY
Kaohsiung J Med Sci; 1999 Sep; 15(9):513-9. PubMed ID: 10561975
[TBL] [Abstract][Full Text] [Related]
25. The expression of laminin-5 in severe dysplasia/carcinoma in situ and early invasive squamous cell carcinoma: an immunohistochemical study.
Rahman F; Rao NN; Tippu SR; Patil S; Agarwal S; Srivastava S
Minerva Stomatol; 2013 May; 62(5):139-46. PubMed ID: 23715200
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
28. Expression of Matrix Metalloproteinase-10 at Invasive Front of Squamous Cell Carcinoma and Verrucous Carcinoma in the Oral Cavity.
Kadeh H; Saravani S; Heydari F; Keikha M; Rigi V
Asian Pac J Cancer Prev; 2015; 16(15):6609-13. PubMed ID: 26434883
[TBL] [Abstract][Full Text] [Related]
29. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma and precursor lesions: clinical pathology.
Woolgar JA; Triantafyllou A
Periodontol 2000; 2011 Oct; 57(1):51-72. PubMed ID: 21781179
[No Abstract] [Full Text] [Related]
31. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.
Wang S; Sun M; Gu C; Wang X; Chen D; Zhao E; Jiao X; Zheng J
Eur J Oral Sci; 2014 Jun; 122(3):202-9. PubMed ID: 24796206
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade.
Liu J; Cao W; Chen W; Xu L; Zhang C
J Oral Pathol Med; 2015 Feb; 44(2):109-14. PubMed ID: 25060050
[TBL] [Abstract][Full Text] [Related]
33. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.
Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP
J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemical study of benign lymphoadenosis of oral mucosa].
Li SX; Yu SF; Sun KH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351
[TBL] [Abstract][Full Text] [Related]
36. Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
Heyden A; Huitfeldt HS; Koppang HS; Thrane PS; Bryne M; Brandtzaeg P
J Oral Pathol Med; 1992 Jan; 21(1):7-11. PubMed ID: 1375644
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin downregulation and Twist overexpression since early stages of oral carcinogenesis.
de Freitas Silva BS; Yamamoto-Silva FP; Pontes HA; Pinto Júnior Ddos S
J Oral Pathol Med; 2014 Feb; 43(2):125-31. PubMed ID: 23772858
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer.
Kim JW; Park Y; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Int J Clin Oncol; 2016 Oct; 21(5):883-889. PubMed ID: 27000845
[TBL] [Abstract][Full Text] [Related]
39. T cells are involved in the induction of macrophage phenotypes in oral leukoplakia and squamous cell carcinoma-a preliminary report.
Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
J Oral Pathol Med; 2018 Feb; 47(2):136-143. PubMed ID: 29108105
[TBL] [Abstract][Full Text] [Related]
40. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
